Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.33 |
| ▸ | NPC1 | O15118 | 4/20 | 0.33 |
| ▸ | RAB9A | P51151 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.33 |
| ▸ | SYK | P43405 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19409223 | 0.77 | ADORA2A (0.36) | MAPTL3MBTL1NPC1RAB9ALMNA | |
| SCHEMBL19409220 | 0.74 | ALDH1A1 (0.44) | ALDH1A1MAPTL3MBTL1SMN1; SMN2NPC1 | |
| SCHEMBL13688644 | 0.71 | ALDH1A1 (0.42) | ALDH1A1MAPTLMNA | |
| SCHEMBL27392857 | 0.69 | YTHDC1 (0.63) | ALDH1A1MAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL5433650 | 0.67 | LMNA (0.42) | ALDH1A1MAPTLMNATSHR | |
| SCHEMBL2112227 | 0.67 | ALDH1A1 (0.59) | ALDH1A1MAPTTP53HSD17B10LMNA | |
| SCHEMBL29200836 | 0.67 | L3MBTL1 (0.41) | ALDH1A1L3MBTL1 | |
| SCHEMBL18418874 | 0.67 | NPSR1 (0.40) | ALDH1A1MAPTHSD17B10LMNA | |
| SCHEMBL2234794 | 0.67 | NPSR1 (0.43) | ALDH1A1L3MBTL1SMN1; SMN2TP53HSD17B10 | |
| SCHEMBL19706636 | 0.66 | L3MBTL1 (0.53) | ALDH1A1MAPTL3MBTL1SMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170281501-A1 | 4,5-DIAMINOIMIDAZOLES AS NOVEL DEVELOPER-TYPE OXIDATION DYE PRECURSORS | HENKEL AG & CO. KGAA (DE) | 2017-10-05 | — | — | US | claimed |
| US-20170281501-A1 | 4,5-DIAMINOIMIDAZOLES AS NOVEL DEVELOPER-TYPE OXIDATION DYE PRECURSORS | HENKEL AG & CO. KGAA (DE) | 2017-10-05 | — | — | US | disclosed |
| US-20170281501-A1 | 4,5-DIAMINOIMIDAZOLES AS NOVEL DEVELOPER-TYPE OXIDATION DYE PRECURSORS | HENKEL AG & CO. KGAA (DE) | 2017-10-05 | — | — | US | disclosed |
| US-20170281501-A1 | 4,5-DIAMINOIMIDAZOLES AS NOVEL DEVELOPER-TYPE OXIDATION DYE PRECURSORS | HENKEL AG & CO. KGAA (DE) | 2017-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170281501-A1 | 4,5-DIAMINOIMIDAZOLES AS NOVEL DEVELOPER-TYPE OXIDATION DYE PRECURSORS | KRT18, DHODH, AOC1 | ALDH1A1 45/4885MAPT 905/4885L3MBTL1 4869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.